Oneview Healthcare Launches World’s First Cloud-based Care Experience Platform
Yesterday, Oneview Healthcare (ASX:ONE) announced the launch of CXP Cloud Enterprise, the world’s first and only cloud-based care experience platform. Deploying Microsoft Azure technology, this platform makes it easier for health systems to support personalised, whole person care.
CXP Cloud Enterprise enables health systems to quickly adopt technology for engaging patients, reducing non-clinical demands on care teams and optimising clinical and operational effectiveness. This comes at a critical time to meet the demand for digital services driven by the pandemic.
“The cloud-based platform is a key pillar of our growth strategy,” said James Fitter, Chief Executive Officer for Oneview.
“Being the first and only cloud-based care experience solution gives us a strong competitive advantage and means health systems can rapidly implement the capabilities that meet their needs today while providing the agility, scalability and investment protection to grow as their health system changes. We are excited to know that CXP Cloud Enterprise will help transform the hospital experience for patients, families and care teams.”
“The cloud enablement of Oneview's patient experience platform is a game changer.” added Dr Simon Kos, Healthcare Industry Executive, Microsoft Australia.
“It means that health organisations can deploy more quickly, with greater predictability and less specialised resources, all on the trusted Azure cloud. This is a win for patients, clinicians and healthcare organisations that put patient experience and outcomes first.”
About CXP Cloud Enterprise
The CXP Cloud Enterprise platform was developed in partnership with NYU Langone Health, a leading academic medical centre in New York, who rapidly rolled out the virtual engagement platform across their facilities during the COVID-19 pandemic to address the increased pressure on care teams and patient’s restricted access to family and friends.
Together, NYU Langone and Oneview collaborated on the initial cloud-based version that enabled NYU Langone to implement key capabilities across 400 beds in just weeks.
Yesterday's introduction of CXP Cloud Enterprise delivers the full functionality and integration capabilities of the care experience platform in a faster, easier, more affordable cloud model at the bedside.
Oneview’s CXP Cloud Enterprise
Oneview’s CXP Cloud Enterprise provides full functionality on a secure, reliable cloud deployment with patient education, meal ordering, patient service requests, apps and digital services, virtual rounding, visitation, and translation services. This comprehensive platform can drive more meaningful engagement, improved satisfaction and provides better control and quality of care for both patients and care providers.
Key features now available with cloud deployments include:
- Bedside telehealth consultations from offsite care team members
- Rounding questionnaires and a digital work list
- Clinician screen-casting to help patients understand their condition, treatment and goals
- Automated service requests help nurses reduce call button distractions
- Targeted patient educational resources
- Meal ordering customised for their dietary needs
- On-demand entertainment
- Video chat to connect with friends and family
- Simple integration with current systems for a single, secure platform hosting the latest apps
About Oneview Healthcare
Oneview Healthcare is a global healthcare technology company listed on the Australian Securities Exchange.
For healthcare systems who lead on exemplary care, ONE provides digital tools for patients, families, and caregivers to improve the care experience.
Unifying a facility’s systems, content and services into one digital platform with dedicated devices at the point of care, Oneview helps deliver more control for patients and families, more time for care teams, and less complexity for executives and IT teams.
Oneview is proud to partner with leading healthcare systems in the US, Australia, the Middle East and Asia.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.